Bliss GVS Pharma shares surged 8% after a block deal of 13.26 lakh shares (1.26% equity) valued at ₹25.4 crore. The stock has gained 17% in the past month and shows strong year-to-date and six-month returns of around 16%, highlighting institutional trading interest.